US Patent Issued to Boehringer Ingelheim International on Oct. 27 for "B7H6 x CD3 binding proteins for cancer treatment" (American, Austrian, German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,334, issued on Oct. 27, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"B7H6 x CD3 binding proteins for cancer treatment" was invented by Susanne Hipp (Fuessen, Germany), Paul Adam (Vienna), Michael Dziegelewski (Newburgh, N.Y.), Rajukumar Ganesan (Blue Bell, Pa.), Phillip Nicholas Gorman (Prospect, Conn.), Pankaj Gupta (Scarsdale, N.Y.), Priyanka Gupta (Danbury, Conn.), Marcio Lasaro (Sandy Hook, Conn.), Justin M. Scheer (Ridgefield, Conn.) and Vladimir H. Voynov (Danbury, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel B7H6/CD3 binding proteins. The invention also ...